dabigatran has been researched along with fibrinogen in 17 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 34,477 | 1,707 | 7,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (82.35) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Baghaei, F; Blixter, IF; Gustafsson, KM; Hillarp, A; Lindahl, TL; Sten-Linder, M; Stigendal, L; Strandberg, K | 1 |
| Cheng, A; Hoylaerts, MF; Peetermans, WE; Schneewind, O; VAN Ryn, J; Vanassche, T; Verhaegen, J; Verhamme, P | 1 |
| Harinstein, LM; Morgan, JW; Russo, N | 1 |
| Dager, WE; Dwyre, D; Gosselin, RC; Kitchen, S | 1 |
| Fountzilas, C; George, J; Levine, R | 1 |
| Barclay, ML; Begg, EJ; Chin, PK; Jensen, BP; Patterson, DM; Wright, DF; Zhang, M | 1 |
| Bailleul, E; Chatelain, B; Coucke, W; Demulder, A; Devreese, K; Douxfils, J; Jochmans, K; Mullier, F; Soumali, MR; Van Blerk, M; Van de Walle, P; Vernelen, K; Wijns, W | 1 |
| Gosselin, R; Kim, YA; Van Cott, EM | 1 |
| Grottke, O; Honickel, M; Rossaint, R; Tillmann, S; Treutler, S; van Ryn, J | 1 |
| Beavers, C; Pahs, L; Schuler, P | 1 |
| Ardillon, L; Boon, LM; Eeckhoudt, S; Hermans, C; Lambert, C | 1 |
| Fredenburgh, JC; Leslie, BA; Stafford, AR; Weitz, JI; Yeh, CH | 1 |
| Claushuis, TA; de Stoppelaar, SF; Ottenhoff, R; Roelofs, JJ; Stroo, I; van der Poll, T; Van't Veer, C | 1 |
| Fujimorl, Y; Katagiri, H; Mitsuhashi, T; Murata, M; Ohir A, K; Shimizur, N; Wakui, M | 1 |
| Bousounis, A; Ho, WK; Hogan, C; Kanda, GS; Rodrigues, C | 1 |
| Artang, R; Brod, C; Nielsen, JD | 1 |
| Chen, H; Gu, H; Hu, L; Lin, X; Liu, H; Xu, Z; Yang, X | 1 |
1 review(s) available for dabigatran and fibrinogen
| Article | Year |
|---|---|
Treatment of dabigatran-associated bleeding: case report and review of the literature.
Topics: Aged, 80 and over; Algorithms; Antithrombins; Benzimidazoles; Dabigatran; Factor VIIa; Factor VIII; Fibrinogen; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Plasma; Pyridines; Renal Dialysis; Treatment Outcome | 2013 |
16 other study(ies) available for dabigatran and fibrinogen
| Article | Year |
|---|---|
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
Topics: Activated Protein C Resistance; Administration, Oral; Adult; Aged; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time; Reproducibility of Results; Thrombin | 2011 |
Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence.
Topics: Animals; Bacterial Adhesion; Benzimidazoles; beta-Alanine; Dabigatran; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Immunohistochemistry; Mice; Placebos; Staphylococcus aureus; Thrombin; Virulence | 2011 |
Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: a multicenter, in vitro study.
Topics: Antithrombins; Benzimidazoles; Canada; Dabigatran; Dose-Response Relationship, Drug; Fibrinogen; Humans; In Vitro Techniques; International Normalized Ratio; Partial Thromboplastin Time; Prodrugs; Pyridines; Reproducibility of Results; Thrombin Time; United Kingdom; United States | 2012 |
Dabigatran overdose secondary to acute kidney injury and amiodarone use.
Topics: Acute Kidney Injury; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Creatinine; Dabigatran; Drug Overdose; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Thrombin Time | 2013 |
Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Female; Fibrinogen; Humans; Linear Models; Male; Middle Aged; Partial Thromboplastin Time; Pyridines; Thrombin Time | 2014 |
Influence of dabigatran and rivaroxaban on routine coagulation assays. A nationwide Belgian survey.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Belgium; Benzimidazoles; beta-Alanine; Biomarkers; Blood Coagulation; Dabigatran; Dose-Response Relationship, Drug; Equipment Design; Fibrinogen; Health Care Surveys; Humans; Laboratory Proficiency Testing; Morpholines; Observer Variation; Partial Thromboplastin Time; Predictive Value of Tests; Prothrombin Time; Quality Indicators, Health Care; Reproducibility of Results; Rivaroxaban; Thiophenes; Time Factors | 2015 |
The effects of dabigatran on lupus anticoagulant, diluted plasma thrombin time, and other specialized coagulation assays.
Topics: Anticoagulants; Antithrombins; Blood Cells; Blood Coagulation; Cells, Cultured; Dabigatran; False Positive Reactions; Fibrinogen; Humans; International Normalized Ratio; Lupus Coagulation Inhibitor; Protein C; Protein S; Randomized Controlled Trials as Topic; Thrombin Time | 2015 |
Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
Topics: Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Antifibrinolytic Agents; Antithrombins; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Coagulants; Dabigatran; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinogen; Infusions, Intravenous; Male; Multiple Trauma; Swine; Thrombin; Time Factors; Tranexamic Acid | 2015 |
The Real-World Treatment of Hemorrhages Associated With Dabigatran and Rivaroxaban: A Multicenter Evaluation.
Topics: Aged; Aged, 80 and over; Antithrombins; Blood Coagulation Factors; Coagulants; Cohort Studies; Dabigatran; Epistaxis; Erythrocyte Transfusion; Factor VIIa; Factor VIII; Female; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Plasma; Platelet Transfusion; Recombinant Proteins; Retrospective Studies; Rivaroxaban | 2015 |
Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations.
Topics: Adult; Anticoagulants; Blood Platelets; Dabigatran; Disseminated Intravascular Coagulation; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Platelet Count; Thrombosis; Vascular Malformations | 2016 |
Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function.
Topics: Allosteric Regulation; Antithrombins; Arginine; Binding Sites; Biocatalysis; Blood Coagulation; Catalytic Domain; Dabigatran; Fibrin; Fibrinogen; Humans; Pipecolic Acids; Protein Binding; Substrate Specificity; Sulfonamides; Surface Plasmon Resonance; Thrombin | 2016 |
Thrombin contributes to protective immunity in pneumonia-derived sepsis via fibrin polymerization and platelet-neutrophil interactions.
Topics: Animals; Blood Coagulation; Blood Platelets; Cell Communication; Dabigatran; Extracellular Traps; Female; Fibrin; Fibrinogen; Flow Cytometry; Humans; Immune System; Immunity, Innate; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Mice, Inbred C57BL; Microcirculation; Neutrophils; Pneumonia, Bacterial; Sepsis; Thrombin | 2017 |
[Potential Application of Fibrinogen Measurement Based on the Clauss Assay to Monitoring of Dabigatran].
Topics: Blood Coagulation Tests; Dabigatran; Fibrinogen; Humans | 2016 |
Pitfalls in the assessment of disseminated intravascular coagulation in patients on dabigatran.
Topics: Administration, Oral; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Partial Thromboplastin Time; Prothrombin Time; Reproducibility of Results; Thrombin; Thrombin Time | 2021 |
Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 5000.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Dabigatran; Factor Xa; Factor Xa Inhibitors; Fibrinogen; Hemorrhage; Humans; Kaolin; Male; Pyridones; Rivaroxaban; Thrombelastography | 2022 |
Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations.
Topics: Adult; Anticoagulants; Blood Coagulation Disorders; Child; Dabigatran; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Pain; Retrospective Studies; Vascular Malformations | 2023 |